Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
- 7 January 2010
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 138 (1) , 25-31
- https://doi.org/10.1016/j.ijcard.2008.08.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in WomenCirculation, 2008
- Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 UpdateCirculation, 2007
- Ambulatory hypercholesterolemia management in patients with atherosclerosisJournal of General Internal Medicine, 2005
- Drug Treatment of Hyperlipidemia in WomenJAMA, 2004
- Epidemiology of coronary heart disease in womenProgress in Cardiovascular Diseases, 2004
- Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in womenJournal of General Internal Medicine, 2003
- Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statementThe Lancet, 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.Circulation, 1994